產(chǎn)品詳情
Cat#: 120P22
序列(三字母):H-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH?
序列(單字母):VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH?
類似名:Calcitonin Gene-Related Peptide I (8-37) (mouse, rat), CGRP-I (8-37) (mouse, rat)
分子式:C???H???N??O??
分子量:3127.56
CAS#:129121-73-9
合成方法:固相合成
存儲(chǔ)條件:-20 ± 5 °C,避光,干燥
描述:α-CGRP (8-37), a competitive CGRP1 receptor antagonist, exhibited hypothermic and antinociceptive effects. CGRP-I (8-37) antagonized the effects of amylin and amylin (1-8) on osteoblasts but was substantially less potent in this regard than amylin (8-37). Furthermore, it inhibited the evoked discharge frequency of wide dynamic range neurons in dorsal horn of the spinal cord in rats.
1)通過電話(+86-(0)-18115476705)郵件([email protected])聯(lián)系我們;
2)提供合成多肽的具體需求,包括序列、質(zhì)量和純度,技術(shù)部門評(píng)估后給與報(bào)價(jià)。
3)簽訂多肽合成合同,交付合成預(yù)付款,科研機(jī)構(gòu)先使用再付款!
4)合成過程定期跟您匯報(bào)合成進(jìn)度及情況;
5)根據(jù)合同內(nèi)容,隨貨提供發(fā)票;
6)如因本公司原因不能交貨或合成失敗,退還所有合成款!
Copyright ?2020 南京肽谷生物科技有限公司 備案號(hào):蘇ICP備19062824號(hào)-1 網(wǎng)站地圖